RT Book, Section
A1 Patel, Manesh R.
A1 Kandzari, David E.
A1 Shah, Rohan
A1 Harrington, Robert A.
A2 Samady, Habib
A2 Fearon, William F.
A2 Yeung, Alan C.
A2 King III, Spencer B.
SR Print(0)
ID 1146607211
T1 Reading Clinical Trials
T2 Interventional Cardiology, 2e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9780071820363
LK accesscardiology.mhmedical.com/content.aspx?aid=1146607211
RD 2024/04/18
AB On  September  16,  1977,  Andreas  Gruentzig  performed  the  first  coronary  angioplasty  on  a  38-year-old  businessman  with  unstable  angina  and  a  discrete  proximal  left  anterior  descending  (LAD)  artery  lesion.  The  procedure  was  a  success,  and  on  subsequent  angiograms  at  10  years  and  23  years,  the  patient  continued  to  have  a  patent  artery.1,2  Gruentzig  reported  his  first  series  of  favorable  results  and  immediately  called  for  a  prospective  randomized  trial  comparing  it  to  bypass  surgery.3,4  The  field  of  interventional  cardiology  was  born,  and  percutaneous  transluminal  coronary  angioplasty  (PTCA)  quickly  spread,  with  multiple  operators  in  many  countries  gaining  experience.